| 1 |
34423649 | Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial. | 2021 Sep 7 |
1 |
| 2 |
31218354 | Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54. | 2019 Oct 1 |
3 |
| 3 |
28750695 | Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial. | 2017 Aug 1 |
1 |
| 4 |
26491109 | Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54. | 2016 Apr 7 |
1 |
| 5 |
26857211 | Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54. | 2016 May 15 |
1 |
| 6 |
26965534 | Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial. | 2016 Mar 15 |
4 |
| 7 |
27576775 | Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54). | 2016 Sep 20 |
3 |
| 8 |
24655690 | Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial. | 2014 Apr |
1 |